{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:22:21Z","timestamp":1762899741613,"version":"3.40.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.urology.2019.04.017","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T19:45:52Z","timestamp":1556221552000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Three-year Active Surveillance Outcomes in a Contemporary Community Urology Cohort in the United States"],"prefix":"10.1016","volume":"130","author":[{"given":"Jeremy B.","family":"Shelton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Paivanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Buffington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Ruyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6509-1562","authenticated-orcid":false,"suffix":"II","given":"Richard","family":"Natale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Mehlhaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Bradford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alec S.","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"Shore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2019.04.017_bib0001","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.juro.2017.11.095","article-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part I: risk stratification, shared decision making, and care options","volume":"199","author":"Sanda","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.04.017_bib0002","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"year":"2018","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Prostate Cancer","key":"10.1016\/j.urology.2019.04.017_bib0003"},{"key":"10.1016\/j.urology.2019.04.017_bib0004","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jama.2015.6036","article-title":"Trends in management for patients with localized prostate cancer, 1990-2013","volume":"314","author":"Cooperberg","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2019.04.017_bib0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.eururo.2014.08.024","article-title":"Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer","volume":"67","author":"Womble","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2019.04.017_bib0006","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jamaoncol.2016.3600","article-title":"Uptake of active surveillance for very-low-risk prostate cancer in Sweden","volume":"3","author":"Loeb","year":"2017","journal-title":"JAMA Oncol"},{"year":"2018","series-title":"The State of Urology Workforce and Practice in the United States 2017","key":"10.1016\/j.urology.2019.04.017_bib0007"},{"key":"10.1016\/j.urology.2019.04.017_bib0008","first-page":"221","article-title":"2014\u20132016: how far has LUGPA come?","volume":"18","author":"Kirsh","year":"1999","journal-title":"Rev Urol"},{"issue":"1","key":"10.1016\/j.urology.2019.04.017_bib0009","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.2009.24.2180","article-title":"Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer","volume":"28","author":"Klotz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2019.04.017_bib0010","first-page":"66","article-title":"Inclusion of comorbidity into oncology data registries","volume":"26","author":"Piccirillo","year":"1999","journal-title":"J Registry Manag"},{"key":"10.1016\/j.urology.2019.04.017_bib0011","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.juro.2015.08.087","article-title":"Outcomes of activesurveillance for clinically localized prostate cancer in the prospective, multi-institutional canary PASS cohort","volume":"195","author":"Newcomb","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.04.017_bib0012","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1464-410X.2012.11434.x","article-title":"Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer","volume":"110","author":"Bul","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2019.04.017_bib0013","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eururo.2014.06.010","article-title":"Five-year nationwide follow-up study of active surveillance for prostate cancer","volume":"67","author":"Loeb","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2019.04.017_bib0014","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2019.04.017_bib0015","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1200\/JCO.2015.62.5764","article-title":"Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer","volume":"33","author":"Tosoian","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2019.04.017_bib0016","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.juro.2014.09.094","article-title":"Extended follow-up and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer","volume":"193","author":"Welty","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.04.017_bib0017","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.juro.2016.08.104","article-title":"Racial disparities in active surveillance for prostate cancer","volume":"197","author":"Krishna","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.04.017_bib0018","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.juro.2015.11.075","article-title":"Metastatic prostate cancer in men initially treated with active surveillance","volume":"195","author":"Yamamoto","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.04.017_bib0019","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.juro.2016.06.102","article-title":"Active surveillance for intermediate risk prostate cancer: survival outcomes in the Sunnybrook experience","volume":"196","author":"Musunuru","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.04.017_bib0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11934-017-0726-3","article-title":"Active surveillance for intermediate risk prostate cancer","volume":"18","author":"Klotz","year":"2017","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urology.2019.04.017_bib0021","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1200\/JCO.2010.31.4252","article-title":"Outcomes of active surveillance for men with intermediate-risk prostate cancer","volume":"29","author":"Cooperberg","year":"2011","journal-title":"J Clin Oncol"},{"year":"2018","series-title":"Advancing the Science of Implementation across the Cancer Continuum","author":"Chambers","key":"10.1016\/j.urology.2019.04.017_bib0022"},{"key":"10.1016\/j.urology.2019.04.017_bib0023","unstructured":"Center for Medicare and Medicaid Services. Oncology Care Model. https:\/\/innovation.cms.gov\/initiatives\/Oncology-Care\/. Published 2018. Accessed 10 May 2018."},{"key":"10.1016\/j.urology.2019.04.017_bib0024","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1200\/JCO.2017.74.2940","article-title":"Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer","volume":"36","author":"Spratt","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2019.04.017_bib0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.eururo.2014.05.004","article-title":"A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling","volume":"66","author":"Klein","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2019.04.017_bib0026","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.ejca.2015.07.019","article-title":"A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer","volume":"51","author":"Wolff","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urology.2019.04.017_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2019.01.061","article-title":"Contemporary management of incident prostate cancer in large community urology practices in the United States","author":"Shelton","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2019.04.017_bib0028","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMsa1201141","article-title":"Urologists' use of intensity-modulated radiation therapy for prostate cancer","volume":"369","author":"Mitchell","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2019.04.017_bib0029","doi-asserted-by":"crossref","first-page":"e6929","DOI":"10.1097\/MD.0000000000006929","article-title":"Reimbursement and use of intensity-modulated radiation therapy for prostate cancer","volume":"96","author":"Shahinian","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.urology.2019.04.017_bib0030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1377\/hlthaff.2011.1062","article-title":"Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse","volume":"31","author":"Jacobs","year":"2012","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.urology.2019.04.017_bib0031","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1200\/JCO.2012.42.8466","article-title":"Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer","volume":"30","author":"Aizer","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429519303711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429519303711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T16:56:05Z","timestamp":1563814565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429519303711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":31,"alternative-id":["S0090429519303711"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2019.04.017","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-year Active Surveillance Outcomes in a Contemporary Community Urology Cohort in the United States","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2019.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}